An EEG platform for national and international EEG-based neuroscience (EEGNet)
Project Overview
EEG is a non-invasive, inexpensive, and efficient tool for measuring electrical signals in the brain. The EEGNet platform will provide a standardized, open repository of EEG data for the investigation of biomarkers of brain disorders that manifest themselves during the early years of life, disorders such as autism.
EEGNet will bring together EEG scientists from across Canada and internationally. They will work to improve our ability to combine EEG data from different laboratories by harmonizing the data formats and analytic tools we all use. We will make use of an existing Brain Canada funded platform, the Canadian Open Neuroscience Platform (CONP), to share EEG data across the country. CONP provides broad generic support for neuroscience data-sharing but EEGNet will focus specifically upon EEG data at a much deeper level in terms of improved data analysis tools and studies of patient cohorts with EEG. These tools will be enhanced to allow earlier detection of early EEG abnormalities in (i) infant or child-onset developmental disorders, (ii) psychiatric or behavioural disorders (depression, risk-taking behaviour), (iii) neurodegenerative diseases, as well as the study of states of consciousness (sleep, wakefulness, coma, anaesthesia).
Many EEGNet researchers also form part of the Global Brain Consortium (GBC) as well as CONP. GBC is focussed on EEG-mediated international neuroscience collaboration. It includes partners from China, the US, Canada, Europe, Australia and Latin America. A primary GBC focus is population screening in Low-and Middle Income Countries. As part of GBC, we seek to place Canada at the centre of an international network using EEG to investigate brain health disorders emerging in early childhood or adolescence in under-served populations around the world.
Principal Investigator
Alan Evans , Montreal Neurological Institute and Hospital, McGill University
Team Members
Mayada Elsabbagh, McGill University
Yves De Koninck, Université Laval
Philippe Albouy, Université Laval
Shirley Fecteau, Université Laval
Isabelle Blanchette, Université Laval
Célyne Bastien, Université Laval
Christophe Grova, Concordia University
Anne Gallagher, Université de Montréal
Sarah Lippé, Sainte-Justine University Hospital Research Centre
Sid Segalowitz, Brock University
Adrian Owen, University of Western Ontario
Ingrid Johnsrude, University of Western Ontario
Stefanie Blain-Moraes, McGill University
Faranak Farzan, Centre for Addiction and Mental Health
Jorge Bosch Bayard, McGill University
Signe Bray, University of Calgary
Ashley Harris, University of Calgary
Sean Hill, University of Toronto
Jean Gotman, McGill University
Birgit Frauscher, McGill University
Stefon Van Noordt, McGill University
Erin Panda, Brock University
Ayda Tekok-Kilic, Brock University
Christine Lackner, Mount St. Vincent University
Karen Campbell, Brock University
Teena Willoughby, Brock University
Partners and Donors
McGill University
CIUSSS-CN (CERVO Brain Research Centre)
Brock University